Clinical Research Facility

Munster, Indiana 46321

Use our guide to learn which trials are right for you!

We've found
11 trials
at this facility
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Munster, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Munster, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Munster, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Munster, IN
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Munster, IN
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Munster, IN
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling, Phase III
Updated: 4/7/2016
mi
from
Munster, IN
Click here to add this to my saved trials
Head and Neck Squamous Cell Carcinoma HNSCC Clinical Trial
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
Status: Enrolling, Phase II
Updated: 9/23/2015
mi
from
Munster, IN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)
Status: Enrolling, Phase III
Updated: 5/31/2017
mi
from
Munster, IN
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction (HFpEF) Clinical Trial
DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fraction
Status: Upcoming, Phase III
Updated: 12/31/1969
mi
from
Munster, IN
Click here to add this to my saved trials
Heart Failure With Reduced Ejection Fraction (HFrEF) Clinical Trial
DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection Fraction
Status: Upcoming, Phase III
Updated: 12/31/1969
mi
from
Munster, IN
Click here to add this to my saved trials